サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1434719

抗コクシジウム薬市場：種類別、動物の種類別-2024-2030年の世界予測

Anticoccidial Drugs Market by Type (Antibiotic Anticoccidials, Chemical Derivative Anticoccidials, Ionophore Anticoccidials), Animal Type (Aquaculture, Livestock, Poultry) - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 185 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
抗コクシジウム薬市場：種類別、動物の種類別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

抗コクシジウム薬市場規模は2023年に16億2,000万米ドルと推計され、2024年には17億6,000万米ドルに達し、CAGR 9.39%で2030年には30億4,000万米ドルに達すると予測されます。

抗コクシジウム薬の世界市場

主な市場の統計
基準年[2023］ 16億2,000万米ドル
予測年[2024］ 17億6,000万米ドル
予測年 [2030] 30億4,000万米ドル
CAGR（%） 9.39%
抗コクシジウム薬 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは抗コクシジウム薬市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、抗コクシジウム薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-抗コクシジウム薬市場の市場規模および予測は？

2-抗コクシジウム薬市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-抗コクシジウム薬市場における技術動向と規制の枠組みは？

4-抗コクシジウム薬市場における主要ベンダーの市場シェアは？

5-抗コクシジウム薬市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 家畜のコクシジウム症の有病率上昇
      • 畜産慣行の改善が進む
      • 動物福祉の向上に向けた政府投資の増加
    • 抑制要因
      • 抗コクシジウム薬に対する政府の厳しい規制
    • 機会
      • 先進的な抗コクシジウム薬の開発
      • メーカーによるコクシジウム症対策の取り組みのイントロダクション
    • 課題
      • 代替薬と治療法の利用可能性
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 抗コクシジウム薬市場：種類別

  • 抗生物質抗コクシジウム剤
  • 化学誘導体抗コクシジウム剤
  • イオノフォア抗コクシジウム剤

第7章 抗コクシジウム薬市場：動物の種類別

  • 水産養殖
  • 家畜
  • 家禽

第8章 南北アメリカの抗コクシジウム薬市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の抗コクシジウム薬市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの抗コクシジウム薬市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Bioproperties Pty Ltd.
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Cronus Pharma
    • Elanco Animal Health Inc.
    • Fengchen Group Co., Ltd.
    • Hipra Laboratories, S.A.
    • Huvepharma EOOD
    • Impextraco NV
    • Intas Pharmaceuticals Ltd.
    • Jurox Pty Limited
    • Kaken Pharmaceutical Co. Ltd.
    • Kemin Industries Inc.
    • Merck & Co., Inc.
    • Novartis AG
    • Phibro Animal Health Corporation
    • Qilu Animal Health Products Co., Ltd.
    • Salius Pharma Pvt. Ltd.
    • TOKU-E
    • VH Group
    • Virbac Group
    • VIVAN Life Sciences Pvt. Limited
    • Zoetis Inc.
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ANTICOCCIDIAL DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTICOCCIDIAL DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANTICOCCIDIAL DRUGS MARKET DYNAMICS
  • FIGURE 7. ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
  • FIGURE 10. ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ANTICOCCIDIAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. ANTICOCCIDIAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANTICOCCIDIAL DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANTIBIOTIC ANTICOCCIDIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANTICOCCIDIAL DRUGS MARKET SIZE, BY CHEMICAL DERIVATIVE ANTICOCCIDIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORE ANTICOCCIDIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 10. ANTICOCCIDIAL DRUGS MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANTICOCCIDIAL DRUGS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ANTICOCCIDIAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 100. ANTICOCCIDIAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. ANTICOCCIDIAL DRUGS MARKET LICENSE & PRICING
目次
Product Code: MRR-456C7E86671E

[185 Pages Report] The Anticoccidial Drugs Market size was estimated at USD 1.62 billion in 2023 and expected to reach USD 1.76 billion in 2024, at a CAGR 9.39% to reach USD 3.04 billion by 2030.

Global Anticoccidial Drugs Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.62 billion
Estimated Year [2024] USD 1.76 billion
Forecast Year [2030] USD 3.04 billion
CAGR (%) 9.39%
Anticoccidial Drugs Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anticoccidial Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anticoccidial Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anticoccidial Drugs Market, highlighting leading vendors and their innovative profiles. These include Bioproperties Pty Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Cronus Pharma, Elanco Animal Health Inc., Fengchen Group Co., Ltd., Hipra Laboratories, S.A., Huvepharma EOOD, Impextraco NV, Intas Pharmaceuticals Ltd., Jurox Pty Limited, Kaken Pharmaceutical Co. Ltd., Kemin Industries Inc., Merck & Co., Inc., Novartis AG, Phibro Animal Health Corporation, Qilu Animal Health Products Co., Ltd., Salius Pharma Pvt. Ltd., TOKU-E, VH Group, Virbac Group, VIVAN Life Sciences Pvt. Limited, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Anticoccidial Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Antibiotic Anticoccidials
    • Chemical Derivative Anticoccidials
    • Ionophore Anticoccidials
  • Animal Type
    • Aquaculture
    • Livestock
    • Poultry
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Anticoccidial Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anticoccidial Drugs Market?

3. What are the technology trends and regulatory frameworks in the Anticoccidial Drugs Market?

4. What is the market share of the leading vendors in the Anticoccidial Drugs Market?

5. Which modes and strategic moves are suitable for entering the Anticoccidial Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Anticoccidial Drugs Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of coccidiosis in livestock
      • 5.1.1.2. Growing improvements in animal husbandry practices
      • 5.1.1.3. Increasing government investments in improving animal welfare
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent government regulations for anticoccidial drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of advanced anticoccidial drugs
      • 5.1.3.2. Introduction of coccidiosis management initiatives by manufacturers
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative medicines and treatments
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Anticoccidial Drugs Market, by Type

  • 6.1. Introduction
  • 6.2. Antibiotic Anticoccidials
  • 6.3. Chemical Derivative Anticoccidials
  • 6.4. Ionophore Anticoccidials

7. Anticoccidial Drugs Market, by Animal Type

  • 7.1. Introduction
  • 7.2. Aquaculture
  • 7.3. Livestock
  • 7.4. Poultry

8. Americas Anticoccidial Drugs Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Anticoccidial Drugs Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Anticoccidial Drugs Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Bioproperties Pty Ltd.
    • 12.1.2. Boehringer Ingelheim International GmbH
    • 12.1.3. Ceva Sante Animale
    • 12.1.4. Cronus Pharma
    • 12.1.5. Elanco Animal Health Inc.
    • 12.1.6. Fengchen Group Co., Ltd.
    • 12.1.7. Hipra Laboratories, S.A.
    • 12.1.8. Huvepharma EOOD
    • 12.1.9. Impextraco NV
    • 12.1.10. Intas Pharmaceuticals Ltd.
    • 12.1.11. Jurox Pty Limited
    • 12.1.12. Kaken Pharmaceutical Co. Ltd.
    • 12.1.13. Kemin Industries Inc.
    • 12.1.14. Merck & Co., Inc.
    • 12.1.15. Novartis AG
    • 12.1.16. Phibro Animal Health Corporation
    • 12.1.17. Qilu Animal Health Products Co., Ltd.
    • 12.1.18. Salius Pharma Pvt. Ltd.
    • 12.1.19. TOKU-E
    • 12.1.20. VH Group
    • 12.1.21. Virbac Group
    • 12.1.22. VIVAN Life Sciences Pvt. Limited
    • 12.1.23. Zoetis Inc.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing